Acute ST-segment elevation myocardial infarction: The prognostic importance of lead augmented vector right and leads

Veeresh Patil Hebbal1, Huliyurdurga Srinivasasetty Natraj Setty1, Cholenahalli Manjunath Sathvik1

  • 1Department of Cardiology, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bengaluru, Karnataka, India.

Insights

Electrocardiogram (ECG) leads aVR, V7, V8, and V9 can help predict outcomes in ST-elevation myocardial infarction (STEMI) patients. ST deviation in lead aVR, particularly depression, indicates higher mortality risk in STEMI.

Area of Science:

  • Cardiology
  • Medical Diagnostics
  • Clinical Research

Background:

  • Acute myocardial infarction (MI) presents significant mortality and morbidity risks.
  • Electrocardiograms (ECG) are crucial for diagnosing MI, identifying culprit vessels, and prognostication.
  • The prognostic value of specific ECG leads like augmented vector right (aVR) and V7-V9 in acute MI is often underutilized.

Purpose of the Study:

  • To investigate the clinical utility of lead aVR and leads V7-V9 in predicting outcomes for patients with ST-elevation myocardial infarction (STEMI).
  • To analyze the correlation between ST deviations in these leads and patient mortality.
  • To assess the role of these leads in differentiating anterior wall MI (AWMI) and inferior wall MI.

Main Methods:

  • A cohort of 209 STEMI patients underwent comprehensive ECG (including V7-9) and 2D-ECHO.
  • Patients received revascularization via primary percutaneous coronary intervention.
  • The study analyzed ST deviations in leads aVR, V7, and V8-9 in relation to MI location and patient outcomes over a 1-month follow-up.

Main Results:

  • The study population (85.1% male, 35.8% diabetic, 60.2% smokers) predominantly had AWMI (55.5%).
  • ST deviation in lead aVR was observed in 75.1% of patients (17.7% elevation, 47.1% depression).
  • ST elevation in V7 occurred in 27.6%, and in V8-9 in 7.5%. Crucially, all 11.9% of deaths exhibited lead aVR ST segment deviation (P < 0.001).

Conclusions:

  • ST deviation in lead aVR and V7 can identify high-risk STEMI patients.
  • Lead aVR ST depression is associated with higher mortality than ST elevation, suggesting more extensive myocardial involvement.
  • These underutilized ECG leads offer valuable prognostic information for STEMI management.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
353
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
590
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
276
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
718